A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) – placental lactogen (PL)-family protein.

No full text

Patent (Patents)

Struman, Ingrid; Martial, Joseph; Bajou, Khalid et al.

2011

Permalink
https://hdl.handle.net/2268/109916

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Biochemistry, biophysics & molecular biology

Inventor :

Struman, Ingrid ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire

Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > Département des sciences de la vie

Bajou, Khalid ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire

D'Amico, Salvino ; Université de Liège - ULiège > GIGA-Research

Language :

English

Title (54) :

A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) – placental lactogen (PL)-family protein.

Publication date (43-45) :

25 August 2011

Filing date (22) :

16 February 2011

Patent/publication number (10-11) :

WO 2011/101373 A1

Patent status (13) :

Priority number (30) :

10153766.0

International classification (IPC) (51) :

A61K 38/22 A61K 38/27 A61P 9/10

European classification (ECLA) (52) :

A61K 38/22 A61K 38/27 A61P 9/10

Applicant (71) :

Université de Liege

Publication organism (19) :

WIPO

Available on ORBi :

since 26 January 2012

Statistics

Number of views

99 (11 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics